0000785161-15-000092.txt : 20151217 0000785161-15-000092.hdr.sgml : 20151217 20151217163347 ACCESSION NUMBER: 0000785161-15-000092 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20151217 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20151217 DATE AS OF CHANGE: 20151217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEALTHSOUTH CORP CENTRAL INDEX KEY: 0000785161 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 630860407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10315 FILM NUMBER: 151294050 BUSINESS ADDRESS: STREET 1: 3660 GRANDVIEW PARKWAY STREET 2: SUITE 200 CITY: BIRMINGHAM STATE: AL ZIP: 35243 BUSINESS PHONE: 205-967-7116 MAIL ADDRESS: STREET 1: 3660 GRANDVIEW PARKWAY STREET 2: SUITE 200 CITY: BIRMINGHAM STATE: AL ZIP: 35243 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHSOUTH REHABILITATION CORP DATE OF NAME CHANGE: 19920703 8-K/A 1 reliantamendment8-k.htm 8-K/A 8-K



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): December 17, 2015 (October 1, 2015)

HealthSouth Corporation
(Exact name of Registrant as specified in its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
001-10315
63-0860407
(Commission File Number)
(IRS Employer Identification No.)
 
 
3660 Grandview Parkway, Suite 200, Birmingham, Alabama 35243
(Address of Principal Executive Offices, Including Zip Code)
(205) 967-7116
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Explanatory Note
On October 1, 2015, HealthSouth Corporation (the “Company” or “HealthSouth”) filed a Current Report on Form 8-K (the “Initial Filing”) with the United States Securities and Exchange Commission to report the consummation of its acquisition of the operations of Reliant Hospital Partners, LLC and affiliated entities (“Reliant”). This Current Report on Form 8-K/A amends and supplements Item 9.01 of the Initial Filing to present certain financial statements of Reliant and to present certain unaudited pro forma condensed combined financial statements of the Company in connection with the acquisition of Reliant.
Item 9.01. Financial Statements and Exhibits
(a)
Financial Statements of Business Acquired
The audited consolidated balance sheet of Reliant as of December 31, 2014 and the related audited consolidated statements of operations, members' deficit, and cash flows for the year ended December 31, 2014, together with the notes thereto and the auditor’s report thereon, are filed as Exhibit 99.1 hereto and are incorporated herein by reference.
The unaudited interim condensed consolidated balance sheet of Reliant as of September 30, 2015 and the related unaudited interim condensed consolidated statements of operations, members' (deficit) equity, and cash flows for the nine months ended September 30, 2015 and 2014, together with the notes thereto, are filed as Exhibit 99.2 hereto and are incorporated herein by reference.
(b)
Pro Forma Financial Information
The unaudited pro forma condensed combined balance sheet of HealthSouth as of September 30, 2015 and the unaudited pro forma condensed combined statements of operations for the year ended December 31, 2014 and the nine months ended September 30, 2015 are filed as Exhibit 99.3 hereto and are incorporated herein by reference.
(d)
Exhibits
See Exhibit Index.





SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
HEALTHSOUTH CORPORATION
 
 
 
By:
/S/   JOHN P. WHITTINGTON
 
Name:
John P. Whittington
 
Title:
Executive Vice President, General Counsel
and Corporate Secretary
Dated: December 17, 2015





EXHIBIT INDEX

Exhibit Number
Description of Exhibit
23.1
Consent of BKD, LLP.
99.1
Audited consolidated balance sheet of Reliant as of December 31, 2014 and the related audited consolidated statements of operations, members' deficit, and cash flows for the year ended December 31, 2014, together with the notes thereto and the auditor’s report thereon.
99.2
Unaudited consolidated balance sheet of Reliant as of September 30, 2015 and the related unaudited interim condensed consolidated statements of operations, members' (deficit) equity, and cash flows for the nine months ended September 30, 2015 and 2014.
99.3
Unaudited pro forma condensed combined balance sheet of HealthSouth as of September 30, 2015 and the unaudited pro forma condensed combined statements of operations for the year ended December 31, 2014 and the nine months ended September 30, 2015.


EX-23.1 2 reliantconsentex231.htm EXHIBIT 23.1 Exhibit


Exhibit 23.1


CONSENT OF INDEPENDENT AUDITORS

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-202552) and Form S-8 (No. 333-141702, No. 333-157445, and No. 333-175981) of HealthSouth Corporation of our report dated March 31, 2015 relating to the financial statements of Reliant Hospital Partners, LLC. as of and for the year ended December 31, 2014, which appears in this Current Report on Form 8-K/A dated December 17, 2015.


/s/ BKD LLP
Dallas, Texas
December 17, 2015


EX-99.1 3 reliantfinancialstatements.htm EXHIBIT 99.1 Exhibit

Exhibit 99.1

Reliant Hospital Partners, LLC
Auditor’s Report and Consolidated Financial Statements
December 31, 2014






Reliant Hospital Partners, LLC
December 31, 2014



Contents
    
INDEPENDENT AUDITOR’S REPORT
1

 
 
CONSOLIDATED FINANCIAL STATEMENTS
 
Balance Sheet
3

Statement of Operations
5

Statement of Members’ Deficit
6

Statement of Cash Flows
7

Notes to Consolidated Financial Statements
8




















Independent Auditor’s Report



Board of Directors and Members of
Reliant Hospital Partners, LLC
Richardson, Texas


We have audited the accompanying consolidated financial statements of Reliant Hospital Partners, LLC and its subsidiaries (Company), which comprise the consolidated balance sheet as of December 31, 2014, and the related consolidated statement of operations, members’ deficit and cash flows for the year then ended, and the related notes to the consolidated financial statements.
Management’s Responsibility for the Financial Statements
Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with accounting principles generally accepted in the United States of America; this includes the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
Auditor’s Responsibility
Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement.
An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the consolidated financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.





Board of Directors and Members of
Reliant Hospital Partners, LLC
Page 2
Opinion
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Reliant Hospital Partners, LLC and its subsidiaries as of December 31, 2014, and the results of their operations and their cash flows for the year then ended in accordance with accounting principles generally accepted in the United States of America.

/s/ BKD, LLP
Dallas, Texas
March 31, 2015





Reliant Hospital Partners, LLC
Consolidated Balance Sheet
December 31, 2014

ASSETS
 
 
 
Currents assets
 
Cash
$
29,314,883

Patient accounts receivable, net of allowance;
    2014 - $3,755,046
29,985,411

Estimated amounts due from third-party payers
972,145

Prepaid expenses
3,715,579

Supply inventory and other
1,036,469

 
 
Total current assets
65,024,487

 
 
Property and Equipment, At cost
 
Buildings and land recorded under capital leases
194,142,528

Facility equipment and furniture
22,609,351

Construction in progress
39,994

 
216,791,873

Less accumulated depreciation and amortization
38,639,126

 
 
 
178,152,747

 
 
Other Assets
 
Deferred financing costs, net
3,356,709

Goodwill
60,223,270

Intangible assets, net
7,067,000

Due from affiliates
868,003

Other long-term assets
1,078,096

 
 
 
72,593,078

 
 
Total assets
$
315,770,312




(Continued)
3


Reliant Hospital Partners, LLC
Consolidated Balance Sheet (Continued)
December 31, 2014


Liabilities And Members’ Deficit
 
 
 
Current liabilities
 
Current maturities of long-term debt
$
3,862,500

Current maturities of capital lease obligations
2,363,175

Accounts payable
2,401,627

Accrued bonuses
1,298,316

Accrued benefits
2,985,431

Accrued property taxes
3,213,956

Other accrued expenses
4,962,167

Estimated amounts due to third-party payors
979,017

 
 
Total current liabilities
22,066,189

 
 
Long-term Debt, Less Current Maturities
150,637,500

 
 
Capital Lease Obligations, Less Current Maturities
186,238,796

 
 
Other Long-term Liabilities
6,981,679

 
 
 
365,924,164

 
 
Commitments and Contingencies
 
Members’ Deficit
 
Reliant Hospital Partners, LLC’s deficit
(53,416,858
)
Noncontrolling interests
3,263,006

 
 
Total members’ deficit
(50,153,852
)
 
 
Total liabilities and members’ deficit
$
315,770,312




See Notes to Consolidated Financial Statements
4


Reliant Hospital Partners, LLC
Consolidated Statement of Operations
Year Ended December 31, 2014



Revenue
 
Net patient service revenue
$
247,676,520

Other
1,400,036

 
 
Total revenue
249,076,556

 
 
Expenses
 
Salaries, wages, and benefits
108,826,751

Purchased services and professional fees
16,160,077

Other operating expenses
27,005,812

Rent expense
11,812,386

Depreciation and amortization
13,066,173

Management fees to affiliates
1,000,000

Provision for doubtful accounts
3,437,563

 
 
Total expenses
181,308,762

 
 
Operating income
67,767,794

 
 
Interest expense
(22,605,000
)
 
 
Net income
$
45,162,794

 

Amounts Attributable to Noncontrolling Interests
 
Net Income
$
45,162,794

Less net income attributable to noncontrolling interests
4,184,072

 
 
Net income attributable to Reliant Hospital Partners, LLC
$
40,978,722




See Notes to Consolidated Financial Statements
5


Reliant Hospital Partners, LLC
Consolidated Statement of Members’ Deficit
Year Ended December 31, 2014




 
Reliant
Hospital Partners, LLC
 
Noncontrolling Interests
 
Total
Members’
 Equity
(Deficit)
 
 
 
 
 
 
Balance, January 1, 2014
$
33,807,301

 
$
6,976,493

 
$
40,783,794

 
 
 
 
 
 
Unit-based compensation
350,927

 

 
350,927

Member distributions
(127,824,491
)
 
(7,432,499
)
 
(135,256,990
)
Reliant Hospital Partners, LLC purchase
of noncontrolling interests and other
redemption of interests
(729,317
)
 
(465,060
)
 
(1,194,377
)
Net income
40,978,722

 
4,184,072

 
45,162,794

 
 
 
 
 
 
Balance, December 31, 2014
$
(53,416,858
)
 
$
3,263,006

 
$
(50,153,852
)



See Notes to Consolidated Financial Statements
6


Reliant Hospital Partners, LLC
Consolidated Statement of Cash Flows
Year Ended December 31, 2014



Operating activities
 
Net income
$
45,162,794

Items not requiring cash
 
Depreciation and amortization of property and equipment
12,581,598

Amortization of intangible assets
484,575

Amortization of deferred financing costs
1,747,670

Provision for doubtful accounts
3,437,563

Unit-based compensation
350,927

Changes in
 
Patient accounts receivable
(20,149,864
)
Estimated amounts due from third-party payers
1,425,222

Inventory, prepaid expenses and other
(1,111,568
)
Accounts payable
(2,162,387
)
Accrued expenses and other
223,847

 
 
Net cash provided by operating activities
41,990,377

 


Investing activities
 
Purchase of property and equipment
(1,228,990
)
 


Net cash used in investing activities
(1,228,990
)
 
 
Financing activities
 
Distributions to members
(135,256,990
)
Reliant Hospital Partners, LLC purchase of noncontrolling
    interests and other redemption of interests
(1,194,377
)
Proceeds from issuance of long-term debt
124,667,621

Payment of deferred financing costs
(3,533,321
)
Payments on line of credit
(11,000,000
)
Payments on long-term debt
(15,993,538
)
Payments on capital lease obligations
(2,504,192
)
 
 
Net cash used in financing activities
(44,814,797
)
 
 
Decrease in Cash
(4,053,410
)
 
 
Cash, Beginning of Year
33,368,293

 
 
Cash, End of Year
$
29,314,883

 
 
Supplemental Cash Flows Information
 
Interest paid
$
20,998,582

 
 
Supplemental Disclosures of Noncash Investing Activities


Payables incurred for property and equipment
$
29,028





See Notes to Consolidated Financial Statements
7


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014



Note 1:
Nature of Operations and Summary of Significant Accounting Policies
Nature of Operations and Principles of Consolidation
Reliant Hospital Partners, LLC (RHP) is a Texas limited liability company. RHP and its subsidiaries (Company) operate inpatient rehabilitation hospitals providing physical, occupational and speech therapy services on an inpatient and outpatient basis at eight hospitals in Texas, two hospitals in Massachusetts and one hospital in Ohio. The consolidated financial statements include the accounts of RHP and its subsidiaries. All significant intercompany transactions and balances have been eliminated.
The Company operates seven of its hospitals through multiple tier partnership arrangements in which the hospital operating entity is in a separate partnership and whose owners consist of physician limited partners with RHP controlling the general partnership of each entity and varying amounts of limited partner interests. The term of each partnership is 50 years, commencing on various dates. The partnership agreements contain provisions, which limit the sale, assignment or transfer of a partner’s interest in the partnerships.
Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Patient Accounts Receivable
The Company reports patient accounts receivable for services rendered at net realizable amounts from third-party payers, patients and others. The Company provides an allowance for doubtful accounts based upon a review of outstanding receivables, historical collection information and existing economic conditions. The Company bills third-party payers directly and bills the patient when the patient’s liability is determined. Patient accounts receivable are due in full when billed. Accounts are considered delinquent and subsequently written off as bad debts based on individual credit evaluation and specific circumstances of the account.
Supply Inventory
Supply inventories are stated at the lower of cost, determined using the first-in, first-out method, or market.


8


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Property and Equipment
Property and equipment acquisitions are recorded at cost and are depreciated using the straight-line method over the estimated useful life of each asset. Assets under capital lease obligations, including both land and buildings, are amortized over the shorter of the lease term or their respective estimated useful lives.
At December 31, 2014, fully depreciated assets included in property and equipment was approximately $387,000.
The estimated useful lives for each major depreciable class of property and equipment are as follows:
Buildings and land recorded under capital leases
20 - 25 years
Facility equipment and furniture
3 - 20 years
Deferred Financing Costs
Deferred financing costs represent costs incurred in connection with the issuance or modification of long-term debt. Such costs are being amortized to interest expense over the term of the respective debt using the straight-line method, which approximates the effective interest method. During the year ended December 31, 2014, interest expense of $1,335,399 was recognized due to refinancing the long-term debt. Total interest expense related to debt issuance costs was $1,747,670 in 2014.
Goodwill and Indefinite-lived Intangible Assets
Goodwill and indefinite-lived intangibles are evaluated annually for impairment or more frequently if impairment indicators are present. A qualitative assessment is performed to determine whether the existence of events or circumstances leads to a determination that it is more-likely-than-not the fair value of the reporting unit or indefinite-lived intangible asset is less than its carrying amount. If, based on the evaluation, it is determined to be more-likely-than-not that the fair value is less than the carrying value, then the goodwill or indefinite-lived intangible is tested further for impairment. If the implied fair value of goodwill or the fair value of the indefinite-lived intangible is lower than their carrying amounts, an impairment loss is recognized in an amount equal to the difference. Any subsequent increases in the value of goodwill and indefinite-lived intangibles are not recognized in the financial statements. There was no impairment of goodwill or indefinite-lived intangible assets recognized during the year ended December 31, 2014.
Intangible Assets
The Company’s intangible assets with finite lives are trade names. The trade names are being amortized on a straight-line basis over periods ranging from 5 – 20 years. These assets are periodically evaluated as to the recoverability of their carrying values and more frequently if there are impairment indicators.


9


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Long-lived Asset Impairment
The Company evaluates the recoverability of the carrying value of long-lived assets whenever events or circumstances indicate the carrying amount may not be recoverable. If a long-lived asset is tested for recoverability and the undiscounted estimated future cash flows expected to result from the use and eventual disposition of the asset are less than the carrying amount of the asset, the asset is written down to fair value and an impairment loss is recognized for the amount by which the carrying amount of the long-lived asset exceeds its fair value.
No asset impairment was recognized during the year ended December 31, 2014.
Net Patient Service Revenue
The Company has agreements with third-party payers that provide for payments to the Company at amounts different from its established rates. Net patient service revenue is reported at the estimated net realizable amounts from patients, third-party payers and others for services rendered and includes estimated retroactive revenue adjustments. Retroactive adjustments are considered in the recognition of revenue on an estimated basis in the period the related services are rendered and such estimated amounts are revised in future periods as adjustments become known.
Income Taxes
The Company is not directly subject to income taxes under the provisions of the Internal Revenue Code and applicable state laws. Therefore, taxable income or loss is reported to the individual members for inclusion in their respective tax returns and no provision for federal income taxes are included in the accompanying consolidated statements of operations.
The Company is subject to state income taxes, including the Texas margin tax. These taxes are not significant for the year ended December 31, 2014.
Professional Liability Claims
The Company recognizes an accrual for claim liabilities based on estimated ultimate losses and costs associated with settling claims and a receivable to reflect the estimated insurance recoveries, if any. Professional liability claims are described more fully in Note 5.
Unit-based Compensation
Awards of unit-based compensation are measured at their grant date fair value. Compensation expense is recognized in the accompanying consolidated statement of operations over the vesting period of the respective award. See Note 14 for additional information.


10


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Note 2:
Net Patient Service Revenue
Revenues consist primarily of net patient service revenue that is recorded based on established billing rates less contractual adjustments.
Inpatient and outpatient rehabilitation services rendered to Medicare and Medicaid program beneficiaries are paid at prospectively determined rates. These rates vary according to a patient classification system that is based on clinical and diagnostic factors. The Company is reimbursed for certain services at tentative rates with final settlement determined after submission of annual cost reports and audits thereof by the Medicare and Medicaid administrative contractors.
Approximately 75% of net patient service revenue is from participation in the Medicare program during the year ended December 31, 2014. Net patient service revenue from participation in the Medicaid program has not been a significant source of revenue for the Company.
Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation and change. As a result, it is reasonably possible that recorded estimates will change materially in the near term.
The Company has also entered into payment agreements with certain commercial insurance carriers, health maintenance organizations and preferred provider organizations. The basis for payment to the Company under these agreements includes prospectively determined rates per discharge, discounts from established charges and prospectively determined daily rates.

Note 3:
Concentration of Credit Risk
The Company grants credit without collateral to its patients, most of who reside in areas near the Company’s hospitals and are insured under third-party payer agreements. Substantially all of the Company’s net receivables are due from third-party payers. The mix of net receivables from third-party payers at December 31, 2014 is:
Medicare
76
%
Medicaid
7
%
Blue Cross Blue Shield
10
%
Other third-party payers
7
%
 
100
%



11


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Note 4:
Acquired Intangible Assets and Goodwill
At December 31, 2014, the carrying amount of goodwill was $60,223,270. The goodwill was recorded as the excess of the purchase price over the fair value of the identifiable assets acquired, net of liabilities assumed, from a 2011 acquisition of all of the assets of Reliant Hospital Partners, LLC. This acquisition included varying interests in multiple tier partnerships. The goodwill has been assigned to the Company’s sole reporting unit and includes goodwill attributable to both the Company and noncontrolling interests.
The carrying amount and accumulated amortization of the Company’s identifiable intangible assets were as follows at December 31, 2014:

 
Gross Carrying Amount
 
Accumulated Amortization
 
Net
2014
 
 
 
 
 
Trade names
$
5,881,500

 
$
(1,124,500
)
 
$
4,757,000

Certificates of need
2,310,000

 

 
2,310,000

 
$
8,191,500

 
$
(1,124,500
)
 
$
7,067,000

The trade names are being amortized over periods ranging from 5 – 20 years. The certificates of need have indefinite lives.
Amortization expense related to the identifiable intangible assets was $484,575 for the year ended December 31, 2014. Estimated future intangible asset amortization expense at December 31, 2014 is as follows:
2015
$
484,575

2016
484,575

2017
484,575

2018
484,575

2019
230,575

Thereafter
2,588,125

 
$
4,757,000

Note 5:
Professional Liability Claims
The Company purchases professional liability insurance under a claims-made policy. Under such a policy, only claims made and reported to the insurer during the policy term, regardless of when the incidents giving rise to the claims occurred, are covered. The Company also purchases excess umbrella liability coverage, which provides additional coverage above the basic policy limits up to the amount specified in the umbrella policy.


12


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




The Company recognizes an accrual for claim liabilities based on estimated ultimate losses and costs associated with litigating and settling claims and a receivable to reflect estimated insurance recoveries, if any. Based upon the Company’s claims experience, no accrual has been made for the Company’s estimated professional liability costs as the amount is not expected to be material. It is reasonably possible that this estimate could change materially in the near term.

Note 6:
Lines of Credit
On May 2, 2012, the Company entered into a revolving credit facility agreement with two lenders that provided for cash borrowings under revolving lines of credit or issuances of letters of credit up to $9,000,000 and was to expire on May 2, 2017. On December 31, 2013, the Company amended the credit facility to, among other things, increase the revolving credit borrowings to $22,000,000 for the 180 day period following the effective date and $12,000,000 thereafter. On September 30, 2014, the Company amended the credit facility to, among other things, increase the revolving credit borrowings to $15,000,000. Borrowings and letters of credit are limited to amounts calculated using adjusted EBITDA, the leverage multiple in effect and funded indebtedness. Cash borrowings under the revolving line of credit at December 31, 2014 totaled $0. At December 31, 2014, there were no amounts outstanding under letters of credit. Interest on borrowings under the credit agreement is computed based on the Company’s outstanding balance at the LIBOR rate plus 4.75% with a floor of 5.75%. The interest rate was 5.75% at December 31, 2014.
The Company also pays an annual unused commitment fee of 0.5%. The credit agreement is secured by substantially all assets of the Company and is guaranteed by the parents of the Company. The credit agreement contains limitations customarily found in such agreements on the incurrence of additional debt, investments, dividends and sale or merger of the Company and contains certain financial covenants. The credit agreement matures on December 31, 2018.

Note 7:
Long-term Debt

Prior to the credit facility entered into on May 2, 2012, described below, the Company utilized long-term notes to finance equipment and initial startup needs including supply inventory and operating expenses. The obligor on each note was the operating partnership who utilized the funds. Payment of outstanding balances was guaranteed by RHP and each operating partnership’s limited partners. The working capital and equipment notes were paid off and replaced by the credit facility entered into during May 2012 discussed below. At December 31, 2014, long-term debt includes the following:

Credit facility
$
154,500,000

Less current maturities
(3,862,500
)
 
$
150,637,500



13


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




On May 2, 2012, the Company entered into a $45,000,000 credit facility with a group of institutional lenders, which included a $36,000,000 term loan and was to expire May 2, 2017. The facility was entered into in order to: (1) purchase additional noncontrolling interests, (2) refinance the lines of credit and other long-term indebtedness, (3) provide working capital and (4) fund certain fees associated with the facility funding and the purchase of the limited partner ownership interests. On December 31, 2013, the Company amended the credit facility agreement to increase the credit facility to $70,375,000, which included Term Loan A for $36,000,000 and Term Loan B for $12,375,000 in order to purchase two additional hospitals and to provide working capital. On September 30, 2014, the Company amended the credit facility agreement to increase the credit facility to $169,500,000, in order to fund distributions of accumulated earnings to members. The credit facility matures October 1, 2019, and requires quarterly payments ranging from $965,625 to $1,931,250 plus interest beginning on January 1, 2015, with a final payment at maturity of $125,531,250. Interest on borrowings under the credit agreement is computed based on the Company’s outstanding balance (at the lower of the bank’s prime rate plus 3.75% or the LIBOR rate plus 4.75%). The interest rate was 5.75% at December 31, 2014. The credit agreement is secured by substantially all assets of the Company and is guaranteed by the parent of the Company. The credit agreement contains limitations customarily found in such agreements on the incurrence of additional debt, investments, dividends and sale or merger of the Company and contains certain financial covenants.
In November 2011, RHP purchased additional ownership interests of its subsidiaries from certain limited partners for $3,716,619. $2,477,745 of the purchase was funded through notes payable to the limited partners at 5% interest, payable in three annual installments with the final payment on November 14, 2014. These notes were not collateralized.
Aggregate annual maturities of long-term debt at December 31, 2014 were:
2015
$
3,862,500

2016
3,862,500

2017
7,725,000

2018
7,725,000

2019
131,325,000

 
$
154,500,000



14


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Note 8:
Capital Lease Obligations
The Company is obligated under long-term noncancellable leases for certain buildings and land, which for accounting purposes, qualify as capital leases. The leases have minimum lease terms expiring through 2036 and have imputed interest rates recorded ranging from 7.5% to 8.895%. The lease payments are guaranteed by RHP and each respective operating partnership limited partner for its related lease. Future annual payments on capital lease obligations at December 31, 2014, are shown below:
2015
$
16,879,767

2016
18,478,579

2017
18,770,450

2018
19,083,339

2019
19,240,915

Thereafter
299,219,818

 
391,672,868

Less amount representing interest
(203,070,897
)
Present value of future minimum lease payments
188,601,971

Less current maturities
(2,363,175
)
 
 
Long-term portion
$
186,238,796

At December 31, 2014, property and equipment include the following property under capital leases:
Buildings and land
$
194,142,528

Less accumulated depreciation
(29,936,057
)
 
$
164,206,471



15


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Note 9:
Sale-leaseback Transaction and Operating Leases
At the close of business on December 31, 2013, RHP purchased certain personal property and operations of two hospitals in the Boston area from FS Commonwealth LLC (FSC) and FS Patriot LLC (FSP). Concurrently, an unrelated third-party, HRSE-TST III, LLC (TST) purchased the land and buildings associated with FSP and FSC from HRSE 1 Properties Trust (HRSE1) for $88,000,000. It was determined that the substance of the transaction was that the Company acquired all of the assets of the hospitals, and simultaneously sold the real property to TST in a sale-leaseback transaction. The Company has entered into lease agreements to lease the property from TST for a period of 15 years beginning January 1, 2014. The real estate was valued at $82,000,000 in the business combination. A gain of $6,000,000 realized in this transaction was deferred and is being amortized to income in proportion to rent charged over the term of the lease. At December 31, 2014, the remaining deferred gain of $5,600,000 is included in other long-term liabilities on the accompanying consolidated balance sheet.
The Company leases four facilities and the home office under noncancellable facility lease agreements with terms ranging from 5 – 15 years along with renewal options for periods ranging from 15 – 25 years. The leases also require additional payments for operating expenses, real estate taxes and insurance. The facility lease agreements contain escalation clauses based on fixed terms and changes in the Consumer Price Index. The excess of cumulative rent expense, recognized on a straight-line basis, over cumulative rent payments is recorded as a long-term liability in the accompanying consolidated balance sheet and was approximately $1,382,000 as of December 31, 2014.
Future minimum lease payments at December 31, 2014 were:
2015
$
7,966,033

2016
8,698,913

2017
8,860,513

2018
8,921,531

2019
9,077,241

Thereafter
83,369,837

Future minimum lease payments
$
126,894,068

The lease payments are guaranteed by RHP and each operating partnership limited partner for its related lease. Total rent expense under these lease agreements was approximately $11,909,000 for the year ended December 31, 2014.


16


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Note 10:
Retirement Plan
The Company has a defined contribution pension plan covering substantially all employees. The Board of Directors annually determines the amount, if any, of the Company’s contributions to the plan. The Board of Directors approved a discretionary contribution for the year ended December 31, 2014 of $150,000 which is included in accounts payable and accrued expenses in the accompanying 2014 consolidated balance sheet.

Note 11:
Related Party Transactions
RHP has an agreement with Nautic Partners VI, L.P. (Nautic), which is a member of RHP’s ultimate parent, Reliant Holding Company, LLC (Holding), to pay management fees of $500,000 annually, until actual annualized or budgeted EBITDA equals or exceeds $20,000,000, when the management fee increases to $1,000,000 annually. The Company’s EBITDA exceeded $20,000,000 during 2014. Nautic received $900,000 of the management fee in 2014, and $100,000 was paid to board consultants in 2014. Additionally, the Company reimburses certain travel costs of Nautic. RHP paid travel costs totaling $47,632 to Nautic for the year ended December 31, 2014, under this agreement.
Nautic is also named in the lawsuit discussed in Note 13.  The Company and Nautic have agreed to share in certain legal costs related to the lawsuit.  Based on the allocation proposed by Nautic’s insurer, the Company has paid and accrued obligations to various firms that include amounts to be reimbursed by Nautic. At December 31, 2014, approximately $868,000, is recorded as a receivable from Nautic included in due from affiliates in the accompanying consolidated balance sheet and as an offset to legal expense.

Note 12:
Fair Value of Financial Instruments
The following methods were used to estimate the fair value of financial instruments recognized in the accompanying balance sheets at amounts other than fair value.
Cash
The carrying amount approximates fair value.
Long-term Debt
Fair value is estimated based on the borrowing rates currently available to the Company for bank loans with similar terms and maturities and determined through the use of a discounted cash flow model. Substantially all long-term debt was modified during 2014 and, therefore, their carrying amount approximates fair value.


17


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Note 13:
Significant Estimates and Concentrations
Accounting principles generally accepted in the United States of America require disclosure of certain significant estimates and current vulnerabilities due to certain concentrations. Those matters include the following:
Cash
At December 31, 2014, the Company’s cash accounts exceeded federally insured limits by approximately $28,522,000.
Allowance for Net Patient Service Revenue Adjustments
Estimates of allowances for adjustments included in net patient service revenue are described in Notes 1 and 2.
Professional Liability Claims
Estimates related to the accrual for professional liability claims are described in Note 5.
Litigation
A lawsuit has been brought against RHP, Old RHP, other parties and selected current and former executives of RHP in Dallas County, Texas, District Court. The plaintiff alleges a number of causes of actions and seeks, among other things, monetary damages and an injunction prohibiting RHP from pursuing any expansion of services in certain markets. RHP has denied any wrongdoing and is defending the case vigorously. On November 18, 2011, the court awarded monetary sanctions against certain former executives of RHP. The Court has not awarded any sanctions against RHP. No potential range of loss, if any, can be estimated. Accordingly, an estimated liability has not been recorded in the accompanying consolidated financial statements. A portion of the Company’s legal expenses were recoverable based on the Company’s insurance policies in effect. As of December 31, 2014, the insurance coverage related to this case and any additional legal expenses or settlements will not be recovered as the maximum insurance payment was fully recovered.
In the normal course of business, the Company is, from time to time, subject to allegations that may or do result in litigation. Some of these allegations are in areas not covered by commercial insurance; for example, allegations regarding employment practices or performance of contracts. The Company evaluates such allegations by conducting investigations to determine the validity of each potential claim. Based upon the advice of counsel, management records an estimate of the amount of ultimate expected loss, if any, for each of these matters. No provisions for potential losses were accrued at December 31, 2014. Events could occur that would cause the estimate of ultimate loss to differ materially in the near term.


18


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Note 14:
Incentive Units
Holding, parent of RHP, issued incentive units in the form of Class B, Class C-1, Class C-2 and Class C-3 units during 2011, 2012 and 2014 to key employees and directors of the Company. The units are considered profits interests, so no capital contributions are required by the holders of the units. The incentive unit holders participate in distributions made by the Company, subject to achievement of certain distribution targets and an order of priority as defined by Holding. The incentive units are accounted for as compensatory awards. The Class B and Class C-1 units granted in 2011 and 2012 vest in five equal annual installments on each anniversary of the grant date, provided that they vest in their entirety upon consummation of a sale of the Company. The Class C-1 units granted in 2014 vested 40% at the time of issuance and the remaining units issued vest in three equal annual installments beginning on January 31, 2015, provided that they vest in their entirety upon consummation of a sale of the Company. The Class C-2 and Class C-3 units vest in their entirety upon the consummation of a sale of the Company, if in connection with the sale of the Company the aggregate consideration payable will result in a target distribution as specified by Holding having been satisfied. In the case of employee termination, only unvested incentive units are returned to the Company. The Company believes that such awards better align the interests of its employees with those of its members.
The Company used an option pricing method to value the incentive units. Under this method, all classes of membership units are modeled as call options on the Company’s underlying equity value, and the rights and preferences of each class of membership are considered in order to allocate a fair value to each class. A significant input of the option pricing method is the enterprise value of the Company, which was estimated utilizing a combination of the income and market approach. The fair value of the incentive units were estimated on the date of grant using a Black-Scholes option valuation model with the assumptions noted in the following table. As the Company does not have a history of market prices for units, expected volatility is based on observable data for a group of peer companies and other factors. The expected term represents the estimated time until a liquidity event. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The fair value of the incentive units also includes a nonmarketability discount of 25%.
Expected volatility
42.16
%
Expected dividend yield
0
%
Expected term (in years)
5

Risk-free rate
1.68
%


19


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Information regarding the amount and grant-date fair value of the vested and nonvested Class B and Class C-1 incentive units is as follows for 2014:
 
Units
 
Weighted-Average Grant-Date Fair Value
Outstanding, beginning of year
3,313,419

 
$
0.45

Granted
 
 
 
Class C-1
94,694

 
$
1.11

Forfeited

 
$

 
 
 
 
Outstanding, end of year
3,408,113

 
$
0.47

 
 
 
 
Vested, beginning of year
1,573,298

 
$
0.44

Class B
20,000

 
$
0.42

Class C-1
672,322

 
$
0.51

Forfeited

 
$

 
 
 
 
Vested, end of year
2,265,620

 
$
0.46

 
 
 
 
Nonvested, end of year
1,142,493

 
$
0.50

The Company recognized compensation expense related to the Class B and Class C-1 incentive units of $350,927 during the year ended December 31, 2014. At December 31, 2014, there was $571,981 of total unrecognized compensation expense related to nonvested incentive units that is expected to be recognized over a weighted-average period of 1.8 years.
Information regarding the amount and grant-date fair value of the Class C-2 and Class C-3 incentive units is as follows for 2014:
 
Units
 
Weighted-Average Grant-Date Fair Value
Outstanding, beginning of year
6,344,442

 
$
0.21

Granted
 
 
 
Class C-2
94,694

 
$
0.68

Class C-3
94,694

 
$
0.44

Forfeited
 
 
 
Class C-2

 
$

Class C-3

 
$

 
 
 
 
Outstanding, end of year
6,533,830

 
$
0.22



20


Reliant Hospital Partners, LLC
Notes to Consolidated Financial Statements
December 31, 2014




Unrecognized compensation expense of $1,470,006 related to the Class C-2 and Class C-3 incentive units will be recognized when they vest, which will occur upon sale of the Company.

Note 15:
Subsequent Event (Unaudited)
On June 10, 2015, HealthSouth Corporation, a Delaware corporation, and it’s newly formed subsidiary, HealthSouth Acquisition Holdings, LLC, a Delaware limited liability company, entered into an acquisition agreement with the Company, Holding, Nautic and additional related parties. The acquisition is expected to close in 2015.


21
EX-99.2 4 reliantinterim2015and2014f.htm EXHIBIT 99.2 Exhibit

Exhibit 99.2

Reliant Hospital Partners, LLC
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
September 30, 2015






Reliant Hospital Partners, LLC

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
September 30, 2015







Contents
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
 
Balance Sheet
1

Statement of Operations
3

Statement of Members’ Deficit
4

Statement of Cash Flows
5

Notes to Consolidated Financial Statements
6














Reliant Hospital Partners, LLC
CONDENSED CONSOLIDATED BALANCE SHEETS
(UNAUDITED)


 
September 30, 2015
 
December 31, 2014
ASSETS
 
 
 
 
 
 
 
Currents assets
 
 
 
Cash
$
45,006,669

 
$
29,314,883

Patient accounts receivable, net of allowance; 2015 - $3,628,029 and 2014 - $3,755,046
27,574,945

 
29,985,411

Estimated amounts due from third-party payers
23,318

 
972,145

Prepaid expenses
8,935,451

 
3,715,579

Supply inventory and other
1,044,263

 
1,036,469

 
 
 
 
Total current assets
82,584,646

 
65,024,487

 
 
 
 
Property and Equipment, At cost
 
 
 
Buildings and land recorded under capital leases
194,142,528

 
194,142,528

Facility equipment and furniture
25,232,837

 
22,609,351

Construction in progress
135,645

 
39,994

 
219,511,010

 
216,791,873

Less accumulated depreciation and amortization
47,582,990

 
38,639,126

 
 
 
 
 
171,928,020

 
178,152,747

 
 
 
 
Other Assets
 
 
 
Deferred financing costs, net
2,826,658

 
3,356,709

Goodwill
60,223,270

 
60,223,270

Intangible assets, net
6,703,569

 
7,067,000

Due from affiliates
868,003

 
868,003

Other long-term assets
995,075

 
1,078,096

 
 
 
 
 
71,616,575

 
72,593,078

 
 
 
 
Total assets
$
326,129,241

 
$
315,770,312




(Continued)
1.


Reliant Hospital Partners, LLC
CONDENSED CONSOLIDATED BALANCE SHEETS (CONTINUED)
(UNAUDITED)

 
September 30, 2015
 
December 31, 2014
Liabilities And Members’ Deficit
 
 
 
 
 
 
 
Current liabilities
 
 
 
Current maturities of long-term debt
$
3,862,500

 
$
3,862,500

Current maturities of capital lease obligations
2,532,378

 
2,363,175

Accounts payable
1,885,697

 
2,401,627

Accrued bonuses
26,680

 
1,298,316

Accrued benefits
3,458,540

 
2,985,431

Accrued property taxes
2,438,170

 
3,213,956

Other accrued expenses
6,218,799

 
4,962,167

Estimated amounts due to third-party payors
1,369,718

 
979,017

 
 
 
 
Total current liabilities
21,792,482

 
22,066,189

 
 
 
 
Long-term Debt, Less Current Maturities
147,740,625

 
150,637,500

 
 
 
 
Capital Lease Obligations, Less Current Maturities
184,143,306

 
186,238,796

 
 
 
 
Other Long-term Liabilities
7,413,710

 
6,981,679

 
 
 
 
 
361,090,123

 
365,924,164

 
 
 
 
Commitments and Contingencies
 
 
 
Members’ Deficit
 
 
 
Reliant Hospital Partners, LLC’s deficit
(38,931,093
)
 
(53,416,858
)
Noncontrolling interests
3,970,211

 
3,263,006

 
 
 
 
Total members’ deficit
(34,960,882
)
 
(50,153,852
)
 
 
 
 
Total liabilities and members’ deficit
$
326,129,241

 
$
315,770,312




See accompanying notes to condensed consolidated financial statements.
2.



Reliant Hospital Partners, LLC
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
NINE MONTHS ENDED SEPTEMBER 30, 2015 AND 2014
(UNAUDITED)


 
2015
 
2014
Revenue
 
 
 
Net patient service revenue
$
193,257,183

 
$
182,498,952

Other
1,176,148

 
1,294,670

 
 
 
 
Total revenue
194,433,331

 
183,793,622

 
 
 
 
Expenses


 


Salaries, wages, and benefits
75,380,870

 
83,078,351

Purchased services and professional fees
15,594,872

 
11,781,746

Other operating expenses
19,916,774

 
20,932,357

Rent expense
8,860,538

 
8,933,623

Depreciation and amortization
9,318,562

 
9,774,290

Fees to affiliates
750,000

 
750,000

Provision for doubtful accounts
1,854,744

 
2,426,105

 
 
 
 
Total expenses
131,676,360

 
137,676,472

 
 
 
 
Operating income
62,756,971

 
46,117,150

 
 
 
 
Interest expense
(19,229,338
)
 
(16,094,804
)
 
 
 
 
Net income
$
43,527,633

 
$
30,022,346

 
 
 
 
Amounts Attributable to Noncontrolling Interests
 
 
 
Net income
$
43,527,633

 
$
30,022,346

Less net income attributable to noncontrolling interests
4,420,409

 
2,970,239

 
 
 
 
Net income attributable to Reliant Hospital Partners, LLC
$
39,107,224

 
$
27,052,107




See accompanying notes to condensed consolidated financial statements.
3.


Reliant Hospital Partners, LLC
CONDENSED CONSOLIDATED STATEMENTS OF MEMBERS' (DEFICIT) EQUITY
NINE MONTHS ENDED SEPTEMBER 30, 2015 AND 2014
(UNAUDITED)



 
Reliant
Hospital Partners, LLC
 
Noncontrolling Interests
 
Total
Members’
 Deficit
 
 
 
 
 
 
Balance, January 1, 2015
$
(53,416,858
)
 
$
3,263,006

 
$
(50,153,852
)
 
 
 
 
 
 
Unit-based compensation
237,109

 

 
237,109

Member distributions
(24,858,568
)
 
(2,608,920
)
 
(27,467,488
)
Reliant Hospital Partners, LLC purchase
of noncontrolling interests and other
redemption of interests

 
(1,104,284
)
 
(1,104,284
)
Net income
39,107,224

 
4,420,409

 
43,527,633

 
 
 
 
 
 
Balance, September 30, 2015
$
(38,931,093
)
 
$
3,970,211

 
$
(34,960,882
)


 
Reliant
Hospital Partners, LLC
 
Noncontrolling Interests
 
Total
Members’
 Equity
 
 
 
 
 
 
Balance, January 1, 2014
$
33,807,301

 
$
6,976,493

 
$
40,783,794

 
 
 
 
 
 
Unit-based compensation
263,195

 

 
263,195

Member distributions
(33,917,906
)
 
(3,269,218
)
 
(37,187,124
)
Reliant Hospital Partners, LLC purchase
of noncontrolling interests and other
redemption of interests
(729,317
)
 
(474,605
)
 
(1,203,922
)
Net income
27,052,107

 
2,970,239

 
30,022,346

 
 
 
 
 
 
Balance, September 30, 2014
$
26,475,380

 
$
6,202,909

 
$
32,678,289




See accompanying notes to condensed consolidated financial statements.
4.


Reliant Hospital Partners, LLC
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
NINE MONTHS ENDED SEPTEMBER 30, 2015 AND 2014
(UNAUDITED)


 
2015
 
2014
Operating activities
 
 
 
Net income
$
43,527,633

 
$
30,022,346

Items not requiring cash
 
 
 
Depreciation and amortization of property and equipment
8,955,131

 
9,410,859

Amortization of intangible assets
363,431

 
363,431

Amortization of deferred financing costs
530,051

 
1,571,058

Provision for doubtful accounts
1,854,744

 
2,426,105

Unit-based compensation
237,109

 
263,195

Changes in
 
 
 
Patient accounts receivable
555,722

 
(16,234,203
)
Estimated amounts due from third-party payers
1,339,528

 
1,748,220

Inventory, prepaid expenses and other
(5,144,644
)
 
(256,683
)
Accounts payable
(515,930
)
 
(1,954,203
)
Accrued expenses and other
120,146

 
2,113,985

 
 
 
 
Net cash provided by operating activities
51,822,921

 
29,474,110

 


 


Investing activities
 
 
 
Purchase of property and equipment
(2,736,201
)
 
(913,916
)
 
 
 
 
Net cash used in investing activities
(2,736,201
)
 
(913,916
)
 
 
 
 
Financing activities


 


Distributions to members
(27,467,488
)
 
(37,187,124
)
Reliant Hospital Partners, LLC purchase of noncontrolling
    interests and other redemption of interests
(1,104,284
)
 
(1,203,922
)
Proceeds from issuance of long-term debt

 
124,667,621

Payment of deferred financing costs

 
(3,449,024
)
Payments on line of credit

 
(11,000,000
)
Payments on long-term debt
(2,896,875
)
 
(15,167,621
)
Payments on capital lease obligations
(1,926,287
)
 
(1,828,422
)
 


 


Net cash (used in) provided by financing activities
(33,394,934
)
 
54,831,508

 
 
 
 
Increase in Cash
15,691,786

 
83,391,702

 


 


Cash, Beginning of Period
29,314,883

 
33,368,293

 
 
 
 
Cash, End of Period
$
45,006,669

 
$
116,759,995

 
 
 
 
Supplemental Cash Flows Information
 
 
 
Interest paid
$
18,731,007

 
$
14,711,319

 
 
 
 
Supplemental Disclosures of Noncash Investing Activities
 
 
 
Payables incurred for property and equipment
$
34,826

 
$
219,192



See accompanying notes to condensed consolidated financial statements.
5.


Reliant Hospital Partners, LLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

Note 1:
Nature of Operations and Summary of Significant Accounting Policies
Nature of Operations and Principles of Consolidation
Reliant Hospital Partners, LLC (RHP) is a Texas limited liability company. RHP and its subsidiaries (Company) operate inpatient rehabilitation hospitals providing physical, occupational and speech therapy services on an inpatient and outpatient basis at eight hospitals in Texas, two hospitals in Massachusetts and one hospital in Ohio. The condensed consolidated financial statements include the accounts of RHP and its subsidiaries. All significant intercompany transactions and balances have been eliminated.
The Company operates seven of its hospitals through multiple tier partnership arrangements in which the hospital operating entity is in a separate partnership and whose owners consist of physician limited partners with RHP controlling the general partnership of each entity and varying amounts of limited partner interests. The term of each partnership is 50 years, commencing on various dates. The partnership agreements contain provisions, which limit the sale, assignment or transfer of a partner’s interest in the partnerships.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of RHP should be read in conjunction with the consolidated financial statements and accompanying notes of RHP’s consolidated financial statements as of and for the year ended December 31, 2014. Certain information and note disclosures included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been omitted in these interim statements. The condensed consolidated balance sheet as of December 31, 2014 has been derived from audited financial statements. However, we believe the disclosures are adequate to make the information presented not misleading.
The unaudited results of operations for the interim periods shown in these financial statements are not necessarily indicative of operating results for the entire year. In our opinion, the accompanying condensed consolidated financial statements recognize all adjustments of a normal recurring nature considered necessary to fairly state the financial position, results of operations, and cash flows for each interim period presented.
Net Patient Service Revenue
The Company has agreements with third-party payers that provide for payments to the Company at amounts different from its established rates. Net patient service revenue is reported at the estimated net realizable amounts from patients, third-party payers and others for services rendered and includes estimated retroactive revenue adjustments. Retroactive adjustments are considered in the recognition of revenue on an estimated basis in the period the related services are rendered and such estimated amounts are revised in future periods as adjustments become known.
Income Taxes
The Company is not directly subject to income taxes under the provisions of the Internal Revenue Code and applicable state laws. Therefore, taxable income or loss is reported to the individual



6.


Reliant Hospital Partners, LLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

members for inclusion in their respective tax returns and no provision for federal income taxes are included in the accompanying condensed consolidated statements of operations.
The Company is subject to state income taxes, including the Texas margin tax. These taxes are not significant for the nine months ended September 30, 2015 and 2014.
Note 2:
Net Patient Service Revenue
Revenues consist primarily of net patient service revenue that is recorded based on established billing rates less contractual adjustments.
Inpatient and outpatient rehabilitation services rendered to Medicare and Medicaid program beneficiaries are paid at prospectively determined rates. These rates vary according to a patient classification system that is based on clinical and diagnostic factors. The Company is reimbursed for certain services at tentative rates with final settlement determined after submission of annual cost reports and audits thereof by the Medicare and Medicaid administrative contractors.
Approximately 75% of net patient service revenue is from participation in the Medicare program during the nine months ended September 30, 2015 and 2014. Net patient service revenue from participation in the Medicaid program has not been a significant source of revenue for the Company.
Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation and change. As a result, it is reasonably possible that recorded estimates will change materially in the near term.
The Company has also entered into payment agreements with certain commercial insurance carriers, health maintenance organizations and preferred provider organizations. The basis for payment to the Company under these agreements includes prospectively determined rates per discharge, discounts from established charges and prospectively determined daily rates.

Note 3:
Concentration of Credit Risk
The Company grants credit without collateral to its patients, most of who reside in areas near the Company’s hospitals and are insured under third-party payer agreements. Substantially all of the Company’s net receivables are due from third-party payers. The mix of net receivables from third-party payers at September 30, 2015 is:
Medicare
76
%
Medicaid
5
%
Blue Cross Blue Shield
6
%
Other third-party payers
13
%
 
100
%

Note 4:
Related Party Transactions



7.


Reliant Hospital Partners, LLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)

RHP has an agreement with Nautic Partners VI, L.P. (Nautic), which is a member of RHP’s ultimate parent, Reliant Holding Company, LLC (Holding), to pay management fees of $500,000 annually, until actual annualized or budgeted EBITDA equals or exceeds $20,000,000, when the management fee increases to $900,000 annually. The Company’s EBITDA exceeded $20,000,000 during the nine months ended September 30, 2015 and 2014. Nautic received $675,000 of the management fee during the nine months ended September 30, 2015 and 2014 and $75,000 was paid to board consultants during the nine months ended September 30, 2015 and 2014. Additionally, the Company reimburses certain travel costs of Nautic. RHP paid travel costs totaling $21,363 and $25,111 to Nautic during the nine months ended September 30, 2015 and 2014, respectively, under this agreement.
Nautic is also named in the lawsuit discussed in Note 5.  The Company and Nautic have agreed to share in certain legal costs related to the lawsuit.  Based on the allocation proposed by Nautic’s insurer, the Company has paid and accrued obligations to various firms that include amounts to be reimbursed by Nautic. At September 30, 2015 and December 31, 2014, approximately $868,000 is recorded as a receivable from Nautic included in due from affiliates in the accompanying consolidated balance sheet and as an offset to legal expense.
Note 5:
Litigation
A lawsuit has been brought against RHP and other parties in Dallas County, Texas, District Court. The plaintiff alleges a number of causes of actions and seeks, among other things, monetary damages and an injunction prohibiting RHP from pursuing any expansion of services in certain markets. RHP has denied any wrongdoing and is defending the case vigorously. On November 18, 2011, the court awarded monetary sanctions against certain former executives of RHP. The Court has not awarded any sanctions against RHP. No potential range of loss, if any, can be estimated. Accordingly, an estimated liability has not been recorded in the accompanying condensed consolidated financial statements. A portion of the Company’s legal expenses were recoverable based on the Company’s insurance policies in effect. As of September 30, 2015, any additional legal expenses or settlements will not be recovered as the maximum insurance payment was fully recovered.
In the normal course of business, the Company is, from time to time, subject to allegations that may or do result in litigation. Some of these allegations are in areas not covered by commercial insurance; for example, allegations regarding employment practices or performance of contracts. The Company evaluates such allegations by conducting investigations to determine the validity of each potential claim. Based upon the advice of counsel, management records an estimate of the amount of ultimate expected loss, if any, for each of these matters. No provisions for potential losses were accrued at September 30, 2015. Events could occur that would cause the estimate of ultimate loss to differ materially in the near term.



8.


Reliant Hospital Partners, LLC
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)


Note 6:
Subsequent Event
On October 1, 2015, HealthSouth Corporation, a Delaware corporation, and it’s newly formed 100%-owned subsidiary, HealthSouth Acquisition Holdings, LLC, a Delaware limited liability company, completed its previously announced acquisition of the operations of the Company and affiliated entities. At closing, one Company entity had a remaining minority limited partner interest of 0.5%. The cash purchase price was reduced by the estimated fair value of this interest. The total consideration delivered at closing was approximately $730 million in cash, which amount includes payment of outstanding borrowings, transaction expenses, and an escrow reserve and is subject to working capital and other adjustments.




9.
EX-99.3 5 reliantproforma2014andinte.htm EXHIBIT 99.3 Exhibit

Exhibit 99.3

HealthSouth and RHP Unaudited Pro Forma Condensed Combined Financial Information

On October 1, 2015, HealthSouth Corporation (the “Company,” “HealthSouth”), completed its previously announced acquisition of the operations of Reliant Hospital Partners, LLC and affiliated entities (“RHP”), that operate 11 free-standing inpatient rehabilitation hospitals with a total of 902 beds in Texas, Massachusetts and Ohio. The acquisition included all of the issued and outstanding equity interest of RHP, except for the parent entity and a 0.5% limited partnership interest in one such entity retained by an unrelated party. The Company funded the cash purchase price with the proceeds from its August 2015 issuance of an additional $350 million of its 5.75% Senior Notes due 2024 and September 2015 issuance of $350 million of 5.75% Senior Notes due 2025, draws under its term loan facilities and revolving credit facility, and cash on hand. The total consideration delivered at closing was approximately $730 million.
The unaudited pro forma condensed combined financial information presented below is derived from the historical financial statements of HealthSouth and RHP, adjusted to give effect to the acquisition and its funding. The unaudited pro forma condensed combined financial information should be read in conjunction with the accompanying notes and the respective historical financial information from which it was derived, which includes the Company’s Form 10-K for the years ended December 31, 2014 and 2013, as well as its Form 10-Q for the quarterly period ended September 30, 2015.
The unaudited pro forma condensed combined balance sheet gives effect to the acquisition and its funding as if they had occurred on September 30, 2015. The unaudited pro forma condensed combined statements of operations for the year ended December 31, 2014 and the nine months ended September 30, 2015 give effect to the acquisition and its funding as if they had occurred on January 1, 2014. The pro forma adjustments are preliminary and have been made solely for informational purposes. The actual results reported by the combined company in periods following the acquisition may differ significantly from that reflected in these unaudited pro forma condensed combined financial statements for a number of reasons, including but not limited to cost savings from operating efficiencies, synergies, and the impact of the incremental costs incurred in integrating the two companies. As a result, the pro forma condensed combined financial information is not intended to represent and does not purport to be indicative of what the combined company’s financial condition or results of operations would have been had the acquisition and its funding been completed on the applicable dates of this pro forma condensed combined financial information. In addition, the pro forma condensed combined financial information does not purport to project the future financial condition and results of operations of the combined company. In the opinion of management, all necessary adjustments to the unaudited pro forma financial information have been made.
The pro forma condensed combined financial statements are based on various assumptions, including assumptions relating to the consideration paid and the allocation thereof to the assets acquired and liabilities assumed based on preliminary estimates of fair value. The pro forma assumptions and adjustments are described in the accompanying notes presented on the following pages. Pro forma adjustments are those that are directly attributable to the acquisition, are factually supportable and, with respect to the unaudited pro forma condensed combined statements of operations, are expected to have a continuing impact on the consolidated results. The final purchase price and the allocation thereof may differ from that reflected in the pro forma condensed combined financial statements after final valuation procedures are performed and estimates are refined. The unaudited pro forma condensed combined financial information does not reflect any cost savings from operating efficiencies or synergies that could result from the acquisition.

1


Unaudited Pro Forma Condensed Combined Balance Sheet



 
As of September 30, 2015
 
Historical
 
Pro Forma Adjustments
 
 
 
HealthSouth
 
RHP
 
Adjustments for Entity Not Purchased
 
Allocation of Acquisition Consideration
 
Pro Forma Combined
 
(In Millions)
Assets
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
801.6

 
$
45.0

 
$
(2.0
)
 
$
(772.3
)
 
$
72.3

Accounts receivable, net
350.9

 
27.6

 

 

 
378.5

Deferred income tax assets
185.9

 

 

 

 
185.9

Other current assets
124.6

 
10.0

 
(5.4
)
 

 
129.2

Total current assets
1,463.0

 
82.6

 
(7.4
)
 
(772.3
)
 
765.9

Property and equipment, net
1,079.1

 
171.9

 

 
48.5

 
1,299.5

Goodwill
1,105.0

 
60.2

 

 
581.0

 
1,746.2

Intangible assets, net
324.7

 
6.7

 

 
59.5

 
390.9

Deferred income tax assets
55.4

 

 

 
(1.8
)
 
53.6

Other long-term assets
222.1

 
4.7

 
(0.9
)
 

 
225.9

Total assets
$
4,249.3

 
$
326.1

 
$
(8.3
)
 
$
(85.1
)
 
$
4,482.0

Liabilities and Shareholders’ Equity
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$
23.6

 
$
6.4

 
$

 
$
(2.3
)
 
$
27.7

Accounts payable
65.6

 
1.9

 
(0.2
)
 

 
67.3

Accrued expenses and other current liabilities
314.4

 
13.5

 
(1.9
)
 
5.0

 
331.0

Total current liabilities
403.6

 
21.8

 
(2.1
)
 
2.7

 
426.0

Long-term debt, net of current portion
2,800.7

 
331.9

 

 
(126.1
)
 
3,006.5

Other long-term liabilities
140.7

 
7.4

 

 

 
148.1

 
3,345.0

 
361.1

 
(2.1
)
 
(123.4
)
 
3,580.6

Commitments and contingencies
 
 
 
 
 
 
 
 
 
Redeemable noncontrolling interests
114.1

 

 

 

 
114.1

Shareholders’ equity:
 
 
 
 
 
 
 
 
 
HealthSouth shareholders’ equity
630.4

 
(38.9
)
 
(6.2
)
 
42.0

 
627.3

Noncontrolling interests
159.8

 
3.9

 

 
(3.7
)
 
160.0

Total shareholders’ equity
790.2

 
(35.0
)
 
(6.2
)
 
38.3

 
787.3

Total liabilities and shareholders’ equity
$
4,249.3

 
$
326.1

 
$
(8.3
)
 
$
(85.1
)
 
$
4,482.0



The accompanying notes are an integral part of this unaudited condensed combined financial information.
2


Unaudited Pro Forma Condensed Combined Statement of Operations



 
For the Year Ended December 31, 2014
 
Historical
 
 
 
Pro Forma Adjustments
 
 
 
HealthSouth
 
RHP
 
Adjustments for Consistent Presentation
 
Adjustments for Entity Not Purchased
 
Acquisition Related Debt Transactions
 
Allocation of Acquisition Consideration
 
Pro Forma Combined
 
(In Millions, Except Per Share Data)
Net operating revenues
$
2,405.9

 
$
249.1

 
$

 
$

 
$

 
$

 
$
2,655.0

Less: Provision for doubtful accounts
(31.6
)
 

 
(3.4
)
 

 

 

 
(35.0
)
Net operating revenues less provision for doubtful accounts
2,374.3

 
249.1

 
(3.4
)
 

 

 

 
2,620.0

Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
1,161.7

 
108.8

 

 
(0.4
)
 

 

 
1,270.1

Purchased services and professional fees

 
16.2

 
(14.2
)
 
(2.0
)
 

 

 

Other operating expenses
351.6

 
27.0

 
4.8

 
(0.3
)
 

 

 
383.1

Occupancy costs
41.6

 
11.8

 

 

 

 

 
53.4

Supplies
111.9

 

 
9.4

 

 

 

 
121.3

General and administrative expenses
124.8

 

 

 

 

 
0.1

 
124.9

Depreciation and amortization
107.7

 
13.1

 

 

 

 
8.8

 
129.6

Management fees to affiliates

 
1.0

 

 
(1.0
)
 

 

 

Provision for doubtful accounts

 
3.4

 
(3.4
)
 

 

 

 

Government, class action, and related settlements
(1.7
)
 

 

 

 

 

 
(1.7
)
Professional fees - accounting, tax, and legal
9.3

 

 

 

 

 

 
9.3

Total operating expenses
1,906.9

 
181.3

 
(3.4
)
 
(3.7
)
 

 
8.9

 
2,090.0

Loss on early extinguishment of debt
13.2

 

 

 

 

 

 
13.2

Interest expense and amortization of debt discounts and fees
109.2

 
22.6

 

 

 
32.9

 

 
164.7

Other income
(31.2
)
 

 

 

 

 

 
(31.2
)
Equity in net income of nonconsolidated affiliates
(10.7
)
 

 

 

 

 

 
(10.7
)
Income from continuing operations before income tax expense
386.9

 
45.2

 

 
3.7

 
(32.9
)
 
(8.9
)
 
394.0

Provision for income tax expense
110.7

 

 

 
1.5

 
(13.1
)
 
12.9

 
112.0

Income from continuing operations
276.2

 
45.2

 

 
2.2

 
(19.8
)
 
(21.8
)
 
282.0

Less: Net income attributable to noncontrolling interest
(59.7
)
 
(4.2
)
 

 

 

 
4.2

 
(59.7
)
Net income from continuing operations attributable to HealthSouth
216.5

 
41.0

 

 
2.2

 
(19.8
)
 
(17.6
)
 
222.3

Less: Convertible perpetual preferred stock dividends
(6.3
)
 

 

 

 

 

 
(6.3
)
Net income from continuing operations attributable to HealthSouth common shareholders
$
210.2

 
$
41.0

 
$

 
$
2.2

 
$
(19.8
)
 
$
(17.6
)
 
$
216.0

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
86.8

 
 
 
 
 
 
 
 
 
 
 
86.8

Diluted
100.7

 
 
 
 
 
 
 
 
 
 
 
100.7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic earnings per share from continuing operations attributable to HealthSouth common shareholders
$
2.40

 
 
 
 
 
 
 
 
 
 
 
$
2.46

Diluted earnings per share from continuing operations attributable to HealthSouth common shareholders
$
2.24

 
 
 
 
 
 
 
 
 
 
 
$
2.30


The accompanying notes are an integral part of this unaudited condensed combined financial information.
3


Unaudited Pro Forma Condensed Combined Statement of Operations



 
For the Nine Months Ended September 30, 2015
 
Historical
 
 
 
Pro Forma Adjustments
 
 
 
HealthSouth
 
RHP
 
Adjustments for Consistent Presentation
 
Adjustments for Entity Not Purchased
 
Acquisition Related Debt Transactions
 
Allocation of Acquisition Consideration
 
Pro Forma Combined
 
(In Millions, Except Per Share Data)
Net operating revenues
$
2,283.6

 
$
194.4

 
$

 
$

 
$

 
$

 
$
2,478.0

Less: Provision for doubtful accounts
(33.2
)
 

 
(1.8
)
 

 

 

 
(35.0
)
Net operating revenues less provision for doubtful accounts
2,250.4

 
194.4

 
(1.8
)
 

 

 

 
2,443.0

Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
Salaries and benefits
1,204.0

 
75.4

 

 
(0.2
)
 

 

 
1,279.2

Purchased services and professional fees

 
15.6

 
(10.7
)
 
(2.1
)
 

 
(2.8
)
 

Other operating expenses
314.1

 
19.9

 
3.6

 
(0.3
)
 

 
(4.5
)
 
332.8

Occupancy costs
37.1

 
8.9

 

 

 

 

 
46.0

Supplies
94.1

 

 
7.1

 

 

 

 
101.2

General and administrative expenses
97.3

 

 

 

 

 
0.2

 
97.5

Depreciation and amortization
98.3

 
9.3

 

 

 

 
7.1

 
114.7

Management fees to affiliates

 
0.8

 

 
(0.8
)
 

 

 

Provision for doubtful accounts

 
1.8

 
(1.8
)
 

 

 

 

Government, class action, and related settlements
8.0

 

 

 

 

 

 
8.0

Professional fees - accounting, tax, and legal
2.7

 

 

 

 

 

 
2.7

Total operating expenses
1,855.6

 
131.7

 
(1.8
)
 
(3.4
)
 

 

 
1,982.1

Loss on early extinguishment of debt
20.0

 

 

 

 

 

 
20.0

Interest expense and amortization of debt discounts and fees
98.3

 
19.2

 

 

 
23.1

 

 
140.6

Other income
(4.2
)
 

 

 

 

 

 
(4.2
)
Equity in net income of nonconsolidated affiliates
(6.3
)
 

 

 

 

 

 
(6.3
)
Income from continuing operations before income tax expense
287.0

 
43.5

 

 
3.4

 
(23.1
)
 

 
310.8

Provision for income tax expense
98.4

 

 

 
1.4

 
(9.3
)
 
15.6

 
106.1

Income from continuing operations
188.6

 
43.5

 

 
2.0

 
(13.8
)
 
(15.6
)
 
204.7

Less: Net income attributable to noncontrolling interest
(50.9
)
 
(4.4
)
 

 

 

 
4.4

 
(50.9
)
Net income from continuing operations attributable to HealthSouth
137.7

 
39.1

 

 
2.0

 
(13.8
)
 
(11.2
)
 
153.8

Less: Convertible perpetual preferred stock dividends
(1.6
)
 

 

 

 

 

 
(1.6
)
Net income from continuing operations attributable to HealthSouth common shareholders
$
136.1

 
$
39.1

 
$

 
$
2.0

 
$
(13.8
)
 
$
(11.2
)
 
$
152.2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
89.1

 
 
 
 
 
 
 
 
 
 
 
89.1

Diluted
101.4

 
 
 
 
 
 
 
 
 
 
 
101.4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic earnings per share from continuing operations attributable to HealthSouth common shareholders
$
1.52

 
 
 
 
 
 
 
 
 
 
 
$
1.69

Diluted earnings per share from continuing operations attributable to HealthSouth common shareholders
$
1.43

 
 
 
 
 
 
 
 
 
 
 
$
1.58


The accompanying notes are an integral part of this unaudited condensed combined financial information.
4


Notes to Unaudited Condensed Combined Pro Forma Financial Information


Note 1 - Basis of Presentation
The unaudited pro forma condensed combined financial information was prepared using the acquisition method of accounting and presents the pro forma combined financial information based upon the historical audited financial statements for the year ended December 31, 2014 and unaudited financial statements as of and for the nine months ended September 30, 2015. Certain adjustments have been made to the historical financial statements of RHP to conform to the presentation and accounting policies of HealthSouth. In addition, adjustments have been made to the historical financial statements of RHP to exclude certain balances or operational activity related to the parent entity, which HealthSouth did not acquire. See Note 3, Unaudited Pro Forma Adjustments.
The accompanying unaudited pro forma condensed combined balance sheet gives effect to the acquisition and its funding as if they had been consummated on September 30, 2015. The unaudited pro forma condensed combined statements of operations give effect to all of the above as if they had been consummated on January 1, 2014.
The unaudited pro forma condensed combined financial information has been prepared for illustrative purposes only and does not purport to represent what the actual consolidated financial position or results of operations of the combined entity would have been had the acquisition and its funding occurred on the dates assumed, nor are they indicative of the combined entity’s future consolidated financial position or results of operations. The pro forma adjustments have been developed based on assumptions and estimates, including assumptions related to the preliminary allocation of the consideration paid to the assets acquired and liabilities assumed of RHP. The final allocation may differ from that reflected in the pro forma financial information after final valuation procedures are performed and amounts are finalized. In addition, the unaudited condensed combined pro forma financial information does not reflect any cost savings from operating efficiencies or synergies that could result from the acquisition.
Note 2 - Preliminary Allocation of Acquisition Consideration
Information regarding the net cash paid for the acquisition of RHP is as follows (in millions):
Fair value of assets acquired, net of $43.0 million of cash acquired
$
322.6

Goodwill
641.2

Fair value of liabilities assumed
(234.3
)
Noncontrolling interest
(0.2
)
Net cash paid for acquisition
$
729.3

Information regarding funding sources for the acquisition is as follows (in millions):
Sources of funds:
 
August 2015 issuance of 5.75% Senior Notes due 2024
$
350.0

September 2015 issuance of 5.75% Senior Notes due 2025
350.0

Term loan/revolving credit facilities and cash
72.3

Total sources
$
772.3



5


Notes to Unaudited Condensed Combined Pro Forma Financial Information


The preliminary fair value of the assets acquired and liabilities assumed at the acquisition date is as follows (in millions):
Cash and cash equivalents
$
43.0

Accounts receivable, net
27.6

Prepaid expenses and other current assets
4.6

Property and equipment, net
220.4

Identifiable intangible assets:
 

Noncompete agreements (useful life of 1 to 2 years)
9.7

Trade names (useful life of 20 years)
8.5

Certificates of need (useful life of 20 years)
36.6

Licenses (useful life of 20 years)
11.4

Goodwill
641.2

Other long-term assets
3.8

Total assets acquired
1,006.8

Current portion of long-term debt
4.1

Accounts payable
1.7

Other current liabilities
11.5

Long-term debt, net of current portion
205.8

Other long-term liabilities
7.4

Deferred tax liabilities
3.8

Total liabilities assumed
234.3

Noncontrolling interests
0.2

Net assets acquired
$
772.3

Assets acquired and liabilities assumed are presented at their estimated fair values. Estimated fair values are based on various valuation methodologies including: replacement cost and continued use methods for property and equipment; an income approach using primarily discounted cash flow techniques for intangible assets related to noncompete agreements, certificates of need, and licenses; an income approach utilizing the relief-from-royalty method for the intangible assets related to trade names; and an estimated realizable value approach using historical trends and other relevant information for accounts receivable and certain accrued liabilities. For all other assets and liabilities, the fair value is assumed to represent carrying value due to their short maturities. The excess of the fair value of the consideration conveyed over the fair value of the net assets acquired is presented as goodwill.
The fair values presented are based upon a preliminary valuation. Estimates and assumptions used in such valuation are subject to change. The primary areas of the preliminary valuation that are not yet finalized relate to the fair values of amounts for income taxes, adjustments to working capital, and the final amount of residual goodwill. We expect to finalize the valuation of the net assets acquired at the acquisition date in February 2016.

6


Notes to Unaudited Condensed Combined Pro Forma Financial Information


Note 3 - Unaudited Pro Forma Adjustments
Unaudited Pro Forma Condensed Combined Balance Sheet
Adjustments for Preliminary Allocation of Acquisition Consideration
The preliminary adjustments to record the assets acquired and liabilities assumed at fair value, eliminate RHP’s historic equity balances, record the payoff of RHP’s debt, excluding capital lease obligations, at the acquisition’s closing, and record HealthSouth’s costs associated with the acquisition are as follows (in millions):
 
Fair Value Adjustments and Elimination of Equity
 
Payoff of RHP Debt at Closing
 
Capital Lease Adjustment
 
HealthSouth Transaction Costs
 
Total Adjustments for Acquisition Consideration
Assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
(591.5
)
 
$
(151.7
)
 
$
(29.1
)
 
$

 
$
(772.3
)
Accounts receivable, net

 

 

 

 

Deferred income tax assets

 

 

 

 

Other current assets

 

 

 

 

Total current assets
(591.5
)
 
(151.7
)
 
(29.1
)
 

 
(772.3
)
Property and equipment, net
(3.8
)
 

 
52.3

 

 
48.5

Goodwill
581.0

 

 

 

 
581.0

Intangible assets, net
59.5

 

 

 

 
59.5

Deferred income tax assets
(3.8
)
 

 

 
2.0

 
(1.8
)
Other long-term assets

 

 

 

 

Total assets
$
41.4

 
$
(151.7
)
 
$
23.2

 
$
2.0

 
$
(85.1
)
Liabilities and Shareholders’ Equity
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$

 
$
(3.9
)
 
$
1.6

 
$

 
$
(2.3
)
Accounts payable

 

 

 

 

Accrued expenses and other current liabilities

 
(0.1
)
 

 
5.1

 
5.0

Total current liabilities

 
(4.0
)
 
1.6

 
5.1

 
2.7

Long-term debt, net of current portion

 
(147.7
)
 
21.6

 

 
(126.1
)
Other long-term liabilities

 

 

 

 

 

 
(151.7
)
 
23.2

 
5.1

 
(123.4
)
Commitments and contingencies
 
 
 
 
 
 
 
 
 
Redeemable noncontrolling interests

 

 

 

 

Shareholders’ equity:
 
 
 
 
 
 
 
 
 
HealthSouth shareholders’ equity
45.1

 

 

 
(3.1
)
 
42.0

Noncontrolling interests
(3.7
)
 

 

 

 
(3.7
)
Total shareholders’ equity
41.4

 

 

 
(3.1
)
 
38.3

Total liabilities and shareholders’ equity
$
41.4

 
$
(151.7
)
 
$
23.2

 
$
2.0

 
$
(85.1
)
See Note 2, Preliminary Allocation of Acquisition Consideration, for information regarding how fair values were determined.

7


Notes to Unaudited Condensed Combined Pro Forma Financial Information


Unaudited Pro Forma Condensed Combined Statements of Operations
Adjustments for Consistent Presentation
Adjustments for consistent presentation for the year ended December 31, 2014 are as follows (in millions):
 
Purchased Services and Professional Fees
 
Supplies
 
Provision for Doubtful Accounts
 
Total Adjustments for Consistent Presentation
Net operating revenues
$

 
$

 
$

 
$

Less: Provision for doubtful accounts

 

 
(3.4
)
 
(3.4
)
Net operating revenues less provision for doubtful accounts

 

 
(3.4
)
 
(3.4
)
Operating expenses:
 
 
 
 
 
 
 
Salaries and benefits

 

 

 

Purchased services and professional fees
(14.2
)
 

 

 
(14.2
)
Other operating expenses
14.2

 
(9.4
)
 

 
4.8

Occupancy costs

 

 

 

Supplies

 
9.4

 

 
9.4

General and administrative expenses

 

 

 

Depreciation and amortization

 

 

 

Management fees to affiliates

 

 

 

Provision for doubtful accounts

 

 
(3.4
)
 
(3.4
)
Government, class action, and related settlements

 

 

 

Professional fees - accounting, tax, and legal

 

 

 

Total operating expenses

 

 
(3.4
)
 
(3.4
)
Loss on early extinguishment of debt

 

 

 

Interest expense and amortization of debt discounts and fees

 

 

 

Other income

 

 

 

Equity in net income of nonconsolidated affiliates

 

 

 

Income from continuing operations before income tax expense

 

 

 

Provision for income tax expense

 

 

 

Income from continuing operations

 

 

 

Less: Net income attributable to noncontrolling interests

 

 

 

Net income from continuing operations attributable to Reliant
$

 
$

 
$

 
$


8


Notes to Unaudited Condensed Combined Pro Forma Financial Information


Adjustments for consistent presentation for the nine months ended September 30, 2015 are as follows (in millions):
 
Purchased Services and Professional Fees
 
Supplies
 
Provision for Doubtful Accounts
 
Total Adjustments for Consistent Presentation
Net operating revenues
$

 
$

 
$

 
$

Less: Provision for doubtful accounts

 

 
(1.8
)
 
(1.8
)
Net operating revenues less provision for doubtful accounts

 

 
(1.8
)
 
(1.8
)
Operating expenses:
 
 
 
 
 
 
 
Salaries and benefits

 

 

 

Purchased services and professional fees
(10.7
)
 

 

 
(10.7
)
Other operating expenses
10.7

 
(7.1
)
 

 
3.6

Occupancy costs

 

 

 

Supplies

 
7.1

 

 
7.1

General and administrative expenses

 

 

 

Depreciation and amortization

 

 

 

Management fees to affiliates

 

 

 

Provision for doubtful accounts

 

 
(1.8
)
 
(1.8
)
Government, class action, and related settlements

 

 

 

Professional fees - accounting, tax, and legal

 

 

 

Total operating expenses

 

 
(1.8
)
 
(1.8
)
Loss on early extinguishment of debt

 

 

 

Interest expense and amortization of debt discounts and fees

 

 

 

Other income

 

 

 

Equity in net income of nonconsolidated affiliates

 

 

 

Income from continuing operations before income tax expense

 

 

 

Provision for income tax expense

 

 

 

Income from continuing operations

 

 

 

Less: Net income attributable to noncontrolling interests

 

 

 

Net income from continuing operations attributable to Reliant
$

 
$

 
$

 
$

The unaudited pro forma condensed combined financial information includes the above reclassification adjustments to conform the RHP statement of operations to HealthSouth’s presentation.

9


Notes to Unaudited Condensed Combined Pro Forma Financial Information


Adjustments for Acquisition Related Debt Transactions
Adjustments for acquisition related debt transactions for the year ended December 31, 2014 are as follows (in millions):
 
Term Loan Facilities
 
Revolving Credit Facility
 
5.75% Senior Notes due 2024
 
5.75% Senior Notes due 2025
 
RHP Debt
 
Total Adjustments for Acquisition Related Debt
Interest expense and amortization of debt discounts and fees
$
2.8

 
$
(2.4
)
 
$
20.2

 
$
19.7

 
$
(7.4
)
 
$
32.9

Adjustments for acquisition related debt transactions for the nine months ended September 30, 2015 are as follows (in millions):
 
Term Loan Facilities
 
Revolving Credit Facility
 
5.75% Senior Notes due 2024
 
5.75% Senior Notes due 2025
 
RHP Debt
 
Total Adjustments for Acquisition Related Debt
Interest expense and amortization of debt discounts and fees
$
2.0

 
$
(1.8
)
 
$
15.4

 
$
15.5

 
$
(8.0
)
 
$
23.1

The unaudited pro forma condensed combined financial information includes the above adjustments for interest expense related to HealthSouth’s funding of the RHP acquisition. In August 2015, HealthSouth issued an additional $350 million of its 2024 Notes at a price of 100.5% of the principal amount, which resulted in approximately $351 million in net proceeds from the private offering. HealthSouth used the net proceeds to reduce borrowings under its revolving credit facility and fund a portion of the RHP acquisition. In September 2015, Healthsouth issued $350 million of 5.75% Senior Notes due 2025 at a price of 100.0% of the principal amount, which resulted in approximately $344 million in net proceeds from the private offering. HealthSouth used the net proceeds from this borrowing to fund a portion of the RHP acquisition. In September 2015, HealthSouth drew from its term loan facilities and revolving credit facility to fund a portion of the RHP acquisition.
Interest rates used in these adjustments represent HealthSouth’s current effective interest rates on the above borrowings as follows:
term loan facilities - 2.25%
revolving credit facility - 2.25%
senior notes - 6.0%, inclusive of financing costs
At closing, HealthSouth repaid all outstanding debt, excluding capital lease obligations, of RHP. Therefore, interest expense associated with these historical borrowings of RHP were eliminated for purposes of this pro forma presentation.
The income tax impact of these interest expense adjustments was estimated using an income tax rate of 40% and resulted in a reduction to income tax expense of $13.1 million and $9.3 million for the year ended December 31, 2014 and the nine months ended September 30, 2015, respectively, for the combined entity.
See Note 8, Long-term Debt, to the financial statements accompanying the Annual Report on Form 10‑K for the year ended 2014.

10


Notes to Unaudited Condensed Combined Pro Forma Financial Information


Adjustments for Allocation of Acquisition Consideration
Adjustments for the allocation of acquisition consideration for the year ended December 31, 2014 are as follows (in millions):
 
Depreciation & Amortization
 
Income Taxes
 
Other
 
Total Adjustments for Acquisition Consideration
Operating expenses:
 
 
 
 
 
 
 
Purchased services and professional fees
$

 
$

 
$

 
$

Other operating expenses

 

 

 

General and administrative expenses

 

 
0.1

 
0.1

Depreciation and amortization
8.8

 

 

 
8.8

Total operating expenses
8.8

 

 
0.1

 
8.9

Loss on early extinguishment of debt

 

 

 

Income from continuing operations before income tax expense
(8.8
)
 

 
(0.1
)
 
(8.9
)
Provision for income tax expense
(3.5
)
 
16.4

 

 
12.9

Income from continuing operations
(5.3
)
 
(16.4
)
 
(0.1
)
 
(21.8
)
Less: Net income attributable to noncontrolling interest

 

 
4.2

 
4.2

Net income from continuing operations attributable to HealthSouth
$
(5.3
)
 
$
(16.4
)
 
$
4.1

 
$
(17.6
)

11


Notes to Unaudited Condensed Combined Pro Forma Financial Information


Adjustments for the allocation of acquisition consideration for the nine months ended September 30, 2015 are as follows (in millions):
 
 
Depreciation & Amortization
 
Transaction Costs
 
Income Taxes
 
Other
 
Total Adjustments for Acquisition Consideration
Operating expenses:
 
 
 
 
 
 
 
 
 
 
Purchased services and professional fees
 
$

 
$
(2.8
)
 
$

 
$

 
$
(2.8
)
Other operating expenses
 

 
(4.5
)
 

 

 
(4.5
)
General and administrative expenses
 

 

 

 
0.2

 
0.2

Depreciation and amortization
 
7.1

 

 

 

 
7.1

Total operating expenses
 
7.1

 
(7.3
)
 

 
0.2

 

Loss on early extinguishment of debt
 

 

 

 

 

Income from continuing operations before income tax expense
 
(7.1
)
 
7.3

 

 
(0.2
)
 

Provision for income tax expense
 
(2.8
)
 
2.9

 
15.6

 
(0.1
)
 
15.6

Income from continuing operations
 
(4.3
)
 
4.4

 
(15.6
)
 
(0.1
)
 
(15.6
)
Less: Net income attributable to noncontrolling interest
 

 

 

 
4.4

 
4.4

Net income from continuing operations attributable to HealthSouth
 
$
(4.3
)
 
$
4.4

 
$
(15.6
)
 
$
4.3

 
$
(11.2
)
Amounts in the above table are preliminary estimates for the following:
Depreciation and amortization - Amounts included in the above table represent adjustments to depreciation and amortization expense based upon the estimated fair values of the property and equipment, capital leases, and definite-lived intangible assets acquired in the acquisition using their estimated remaining useful lives. Total depreciation and amortization consists of the following amounts (in millions):
 
For the Year Ended December 31, 2014
For the Nine Months Ended September 30, 2015
Identifiable intangible assets
$
6.7

$
5.1

Property and equipment
(0.9
)
(0.2
)
Capital leases
3.0

2.2

Total depreciation and amortization
$
8.8

$
7.1

Transaction Costs - Amounts included in the above table represent adjustments for costs incurred as a direct result of the acquisition.
Income Taxes - Amounts included in the above table represent adjustments to reflect HealthSouth’s income tax rate of 40%.
Other - Amounts included in the above table primarily include stock awards assumed to have been granted to members of RHP management during the periods presented and the impact of noncontrolling interests.


12
GRAPHIC 6 bkd.jpg begin 644 bkd.jpg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end